Price means nothing if the pharmacy is a mystery. That is the one thing I care about most when evaluating any compounded GLP-1 program. Cheap tirzepatide from an unnamed lab, with no lot tracking and no LegitScript certification, is not a deal. It is a gamble.
Here are the six programs I would genuinely write a check for.
1. HealthRX: Best Overall Value for Compounded Tirzepatide
Compounded tirzepatide starting at $149 a month, free overnight shipping to all 50 states, and a named 503A pharmacy in Greer, South Carolina called Manifest Pharmacy. That combination is genuinely hard to beat. The pharmacy operates under USP-797 standards with lot-tracked batches, and the program carries LegitScript certification (cert 50087439), which is a publicly verifiable credential, not a self-issued badge.
The intake process is straightforward: you complete an online health assessment, a U.S. board-certified physician reviews it within roughly 24 hours, and the medication ships overnight. No subscription surprises. The published pricing includes no hidden fees, which is rarer than it should be in this space.
For context on what tirzepatide can do: the SURMOUNT-1 trial showed approximately 21% mean body weight loss at 72 weeks in adults with obesity. HealthRX cites that trial-based figure rather than manufacturing its own claims. Worth noting: compounded tirzepatide is not FDA-approved as a finished product, and the FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026. Knowing exactly which pharmacy made your medication, and that it has external certification, matters a lot in that environment.
2. FormBlends: Best for Transparency-First Buyers
FormBlends sits a step above most compounded GLP-1 programs on one specific thing: it publishes per-product purity testing. HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results, with the actual numbers attached. Few GLP-1-only telehealth brands do that.
It is not the cheapest option. Compounded semaglutide runs around $299 and tirzepatide around $349, both notably higher than HealthRX’s entry pricing. Ships to 47 states, not 50. The physician oversight model is similar to most others in this category.
Where FormBlends earns its spot here is for the buyer who wants documented proof of what is in the vial before injecting it, or for someone who also wants peptides for recovery, cognitive support, or longevity. It carries a broader peptide catalog under the same clinician model, which almost no GLP-1-only program offers. If you want GLP-1s and BPC-157 from one provider, this is probably your place.
3. Mochi Health: Best for Medical Oversight at a Low Price
Mochi charges around $199 a month for compounded tirzepatide. More importantly, it staffs board-certified obesity medicine physicians, not just general practitioners. The monitoring is heavier than average for a cash-pay telehealth program. Good fit for someone with a more complicated metabolic history.
4. Henry Meds: Best for Speed
Cash-pay compounded tirzepatide, typically $179 to $249 for the first month, and the shipping window is 24 to 72 hours. Henry Meds does not load on the clinical coaching layers that add cost elsewhere. If your main concern is getting medication quickly without a long intake process, Henry competes well here.
5. MEDVi: Best No-Contract Option
Around $179 for the first month, no long-term contract required. MEDVi is quiet about its pharmacy sourcing compared to programs like HealthRX or FormBlends, which I would push them on before ordering. But for someone who wants to try one month before committing, the no-contract structure is a real advantage.
6. Plush Care: Best If You Have Insurance
PlushCare runs a $19.99 monthly membership and connects you to same-day physician visits for branded GLP-1 prescriptions. Zepbound and Wegovy pricing through insurance with a savings card can bring monthly costs down to near zero in some cases. Not a compounded option, but if you have decent insurance, the math here can beat every cash-pay program on this list by a wide margin.
A reasonable note before you do anything: compounded GLP-1 medications are not FDA-approved finished drug products, the regulatory environment around them changed significantly in early 2026, and what your body does with any of these medications depends on factors no list article can account for. Talk to a physician who knows your full health picture, not just the one doing a 10-minute intake form review.
Common Questions
Is compounded tirzepatide from HealthRX the same molecule as branded Zepbound?
Compounded tirzepatide uses the same active ingredient as Zepbound, but it is not manufactured by Eli Lilly and is not FDA-approved as a finished drug product. The quality depends entirely on the compounding pharmacy. HealthRX’s use of a named 503A pharmacy with USP-797 standards and a verifiable LegitScript certification is what separates it from programs that leave that question unanswered.
Why does FormBlends cost $200 more per month than HealthRX if they both compound tirzepatide?
The price gap reflects FormBlends’ published third-party purity testing, which includes HPLC percentages, mass spec identity confirmation, and endotoxin results with actual numbers attached. That documentation costs money to produce. Whether the premium is worth it depends on how much documented proof of purity matters to you personally before you inject something.
Can I switch between these programs month to month, or will I lose my titration schedule?
Switching programs mid-titration is possible, but it introduces real friction. Each program uses its own dosing protocol, and a new physician reviewing your intake form may restart you at a lower dose for safety reasons. If titration continuity matters, pick one program and stay with it through at least the first three to four months.
What does LegitScript certification actually verify, and which programs on this list have it?
LegitScript is an independent third-party registry that confirms a pharmacy or telehealth program meets specific legal and safety standards, including prescription requirements and licensing. It is a public lookup, not self-reported. Of the programs listed here, HealthRX holds a verifiable certification (cert 50087439). The others are not confirmed to hold it based on publicly available information.
If the FDA issued warning letters to compounding firms in early 2026, should I avoid all compounded tirzepatide programs right now?
The warning letters targeted specific firms, not compounded tirzepatide as a category. The practical takeaway is to verify which pharmacy actually made your medication, whether it holds external certification, and whether its batches are lot-tracked. Buying from a program that cannot answer those questions clearly is the actual risk, not compounding itself.
Sources
- FDA warning letters to compounding telehealth firms, early 2026 (FDA.gov public notices)
- SURMOUNT-1 trial results, Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 trial results, Wilding et al., *New England Journal of Medicine*, 2021
- LegitScript certification registry (legitscript.com, public lookup)
- Novo Nordisk settlement announcement, March 9, 2026 (publicly reported across major outlets)
